Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19).
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 32785632.
- Also identified by DOI 10.1001/jamanetworkopen.2020.17539 and PMC identifier 12124689.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study assesses the prevalence of lupus anticoagulant (LA) positivity in patients with coronavirus disease 2019 (COVID-19) and examines the association of LA positivity with patient outcomes.
Medical subject headings
- Coronavirus Infections
- Lupus Coagulation Inhibitor
- Pneumonia, Viral